In Situ Injection of Anti-angiogenics in Patients With Brain Arteriovenous Malformations Not Eligible for Exclusion Treatment

NCT07075757 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Brain Arteriovenous Malformations

Interventions

DRUG: Single in situ intra-arterial injection of bevacizumab

Sponsor

Assistance Publique - Hôpitaux de Paris